COMMUNIQUÉS West-GlobeNewswire
 
      -   
  Diaxonhit : Assemblée générale ordinaire et extraordinaire annuelle16/06/2017
-   
  FDA posts briefing materials prior to Advisory Committee meeting for Victoza® label update16/06/2017
-   
  Kymab Group Ltd: Kymab appoints Dr Martin Nicklasson as Non-Executive Chair16/06/2017
-   
  Bavarian Nordic Announces Notification of Request for Proposal for Freeze-Dried IMVAMUNE16/06/2017
-   
  Helsinn Investment Fund leads the financial round in GreenBone16/06/2017
-   
  RECORDATI LICENSES AN INNOVATIVE TREATMENT FOR NEUROTROPHIC KERATITIS16/06/2017
-   
  Annual General Meeting of Active Biotech AB16/06/2017
-   
  Bavarian Nordic Provides Update on Anticipated Timing of PROSPECT Study16/06/2017
-   
  PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")16/06/2017
-   
  Idorsia - Reaching out for more16/06/2017
-   
  Johnson & Johnson Completes Acquisition of Actelion16/06/2017
-   
  DBV Technologies annonce la nomination de Julie O'Neill au conseil d'administration15/06/2017
-   
  DBV Technologies Announces Appointment of Julie O'Neill to Board of Directors15/06/2017
-   
  DBV Technologies Annonce les Résultats de son Assemblée Générale Mixte 201715/06/2017
-   
  DBV Technologies Announces Results of its 2017 Ordinary and Extraordinary General Meeting15/06/2017
-   
  NANOBIOTIX a présenté de nouvelles données translationnelles lors du workshop d'Immunothérapie organisé par l'ASTRO, le NCI et le SITC15/06/2017
-   
  NANOBIOTIX : new translational data presented at ASTRO, NCI AND SITC'S Immunotherapy Workshop15/06/2017
-   
  FDA accepts Sandoz regulatory submission for a generic version of Advair Diskus®15/06/2017
-   
  Solon Eiendom ASA - Primary insider notification15/06/2017
Pages